AEON Biopharma Inc. (AEON)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

AEON Biopharma Inc. Borsa (AEON) Ultime notizie

AEON Biopharma Inc. (AEON)

AEON Biopharma Inc. Borsa (AEON) Ultime notizie

AEON Biopharma (AEON) Holds Steady at $0.71 as Stock Consolidates Between Key Support and ResistanceSeasonality Effect - newsline.com

AEON Q4 2025 Earnings: Significant EPS Miss as Pre-Revenue Biotech Faces ChallengesRetail Earnings Report - newsline.com

Number of shareholders of AEON Biopharma, Inc. – AMEX:AEON - TradingView

AEON BIOPHARMA INC (AEON) Stock Chart - ChartMill

AEON Biopharma Presents New Data Supporting Biosimilarity of ABP-450 to BOTOX at AHS 2026 Annual Meeting - Moomoo

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society - The Manila Times

Botox biosimilar ABP-450 shows similar structure and activity - Stock Titan

AEON Biopharma Presents New Data Supporting Biosimilarity of ABP-450 to BOTOX® at AHS 2026 Annual Meeting - Quiver Quantitative

AEON Technical Analysis | Trend, Signals & Chart Patterns | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill

AEON Biopharma (AEON) Surges 5.6% as Bulls Test Key Resistance at $0.80Factor ETF Flow - newsline.com

AEON Biopharma Edges Higher: Stock Rises 2.75% as it Tests Key ResistanceHigh Conviction Picks - The Legal Advocate

AEON Q4 2025 Earnings: Deep EPS Miss Amid Pre-Revenue StageEPS Miss Report - The Legal Advocate

AEON Biopharma Q4 2025 Earnings: Major EPS Miss and No Revenue Weigh on Investor SentimentEarnings Expansion Phase - Newser

AEON Biopharma Inc. (AEON) Q4 2025 Earnings: Significant EPS Miss and Stock Decline Amid Development ChallengesHigh Growth Earnings - Newser

AEON Biopharma Dips 2.74% as Stock Nears Critical Support at $0.76Watchlist Stock Ideas - Newser

AEON Q4 2025 Earnings: Wider-Than-Expected Loss as Biotech Continues Pre-Revenue PhaseAnalyst Earnings Estimate - newsline.com

12 Health Care Stocks Moving In Monday's Intraday Session - Sahm

AEON Stock Price, Quote & Chart | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill

AEON SEC FilingsAeon Biopharma 10-K, 10-Q, 8-K Forms - Stock Titan

AEON Biopharma shares fall over 2% on quarterly loss - Investing.com

AEON Biopharma shares fall over 2% on quarterly loss By Investing.com - Investing.com South Africa

AEON Biopharma Reports Q1 Financial Results - Intellectia AI

AEON Biopharma Releases Updated Investor Relations Presentation - TipRanks

AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

AEON Biopharma (AEON) releases May 2026 corporate investor presentation via Form 8-K - Stock Titan

AEON Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

AEON Biopharma (NYSE: AEON) Q1 2026 loss, financing deals and going concern risk - Stock Titan

AEON Biopharma (NYSE: AEON) Q1 2026 loss, FDA boosts ABP-450 plan and debt cut - Stock Titan

AEON’s Botox biosimilar plan gets FDA feedback as debt falls 90% - Stock Titan

TradingKey - TradingKey

AEON Biopharma (AEON) details 2026 meeting, director elections and KPMG ratification - Stock Titan

AEON Biopharma Sets Annual Shareholder Meeting - The Manila Times

AEON cites going concern audit note, cash into Q3 2026 - Stock Titan

AEON Biopharma receives additional NYSE American non-compliance notice - MSN

AEON Bio (AEON) Stock: Why Brand Strength (Eye on Rally) 2026-04-20Market Movers - Cổng thông tin điện tử tỉnh Tây Ninh

Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Eli Lilly and Company, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories, Amgen, Teva Pharma, Anne Lindblad - Barchart.com

AEON (AEON Biopharma) PB Ratio : (As of Apr. 10, 2026) - GuruFocus

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Weekly Earnings: Will AEON Biopharma Inc be affected by tariffs2026 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn

What is the bull case for AEON Bio (AEON) Stock | AEON Q4 2025 Earnings: AEON Biopharma Inc. misses EPS, no revenue postedAnnual Earnings Summary - newsline.com

Is AEON Bio (AEON) Stock Rebounding | Price at $0.90, Up 1.27%Rip Sell Trade - The Legal Advocate

AEON Biopharma Receives NYSE American Non-Compliance Notice Due to Stockholders’ Equity Deficit and Ongoing Listing Challenges - Minichart

AEON Biopharma Receives Additional NYSE American Noncompliance Notice - The Globe and Mail

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards - The Manila Times

AEON Biopharma, Inc. (AEON) stock price, news, quote and history - Yahoo Finance Singapore

AEON Biopharma Receives Second NYSE American Notice for Listing Non-Compliance - geneonline.com

AEON (AEON) CFO awarded 754,717 restricted stock units vesting over four years - Stock Titan

AEON Biopharma (AEON) CFO John Bencich files initial insider ownership report - Stock Titan

AEON Biopharma Faces Listing Compliance Risk - Intellectia AI

Simile a AEON